NCT02873962: A Phase II Study Of Nivolumab/ Bevacizumab/Rucaparib
- State
- Under way
- Phase
- Phase 2
- People
- 72 taking part
- Started
- 10 Nov 2016
- Primary completion
- Feb 2025
- Arms
- Cohort 1: Nivolumab with Bevacizumab
- Results
- Posted on the registry
- 22 Aug 2016: Trial registered
- 10 Nov 2016: Trial started
- 1 Apr 2026: Trial results posted